Focus: Immunome is a Pennsylvania-based biotechnology company focused on cancer immunotherapy with a pipeline spanning oncology and solid malignancies. The company operates at the clinical-stage level with early-phase programs in development.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
17 added, 16 removed. Backfill posture.
Best suited for early-stage biotech careers willing to accept financial opacity in exchange for deep R&D involvement in immunotherapy innovation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Immunome
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Immunome's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles